Dietary Fats in the Body: Saturated, Omega-3 vs Omega-6, Eicosanoids, and Trans Fats

Dietary lipids represent an indispensable class of macronutrients executing structural, endocrine, and energetic roles. Fatty acids construct the amphipathic lipid bilayer of all cellular and organelle membranes, act as obligatory vehicles for fat-soluble vitamins (A, D, E, K), form the myelin sheaths insulating neuronal axons, and serve as biological precursors to eicosanoid and docosanoid signaling networks.

Fatty acids are classified by aliphatic chain saturation: saturated fatty acids (SFAs), monounsaturated fatty acids (MUFAs), and polyunsaturated fatty acids (PUFAs).

Fatty Acid Subtypes and Membrane Biophysics

• Saturated Fatty Acids (SFAs: Palmitic, Myristic, Lauric, Stearic): Free of carbon-carbon double bonds, SFAs pack densely into crystalline bilayers, conferring mechanical membrane rigidity. However, excess palmitic and myristic acids downregulate hepatic LDL receptor (LDLR) expression, driving elevations in atherogenic circulating ApoB and LDL particles.
• Monounsaturated Fatty Acids (MUFAs / Omega-9: Oleic Acid): Containing a single cis double bond, oleic acid is the primary component of extra virgin olive oil. MUFAs increase membrane fluidity without predisposing lipids to free-radical peroxidation, preserving endothelial function and HDL-mediated reverse cholesterol transport.
• Polyunsaturated Fatty Acids (PUFAs): Possessing two or more double bonds, PUFAs are strictly essential nutrients because human biochemistry lacks desaturase enzymes capable of inserting double bonds beyond the omega-9 position.

Omega-6 vs. Omega-3 Competition: The Eicosanoid Cascade

A primary axis of metabolic regulation centers upon enzymatic competition between omega-6 (parent: linoleic acid, LA) and omega-3 (parent: alpha-linolenic acid, ALA) fatty acids:

1. Shared Microsomal Machinery: Both pathways rely upon rate-limiting delta-6-desaturase (D6D) and delta-5-desaturase enzymes. When dietary omega-6 massively predominates, D6D is monopolized, halting downstream omega-3 elongation.
2. Pro-Inflammatory Omega-6 Arm: Linoleic acid elongates into arachidonic acid (AA). Phospholipase A2 releases AA from membranes to feed cyclooxygenase (COX) and 5-lipoxygenase (5-LOX) enzymes, generating potent mediators of vasoconstriction, chemotaxis, and platelet aggregation: prostaglandin E2 (PGE2), leukotriene B4 (LTB4), and thromboxane A2 (TXA2).
3. Anti-Inflammatory Omega-3 Arm: Long-chain eicosapentaenoic (EPA) and docosahexaenoic (DHA) acids generate Specialized Pro-Resolving Mediators (SPMs: resolvins, protectins, maresins) that actively terminate neutrophil infiltration and orchestrate tissue repair.

The Evolutionary Imbalance: The Seed Oil Surge

• Paleolithic Baseline: Human physiology evolved on an omega-6 to omega-3 ratio approximately between 1:1 and 4:1.
• Modern Western Diets: Ubiquitous consumption of industrial seed oils (sunflower, corn, soybean) has skewed this ratio to 15:1 or 20:1, generating a persistent pro-thrombotic and pro-inflammatory metabolic background.

Industrial Trans Fats: A Non-Negotiable Vascular Hazard

Partially hydrogenated vegetable oils generate trans-isomers with unnatural rigid geometry:

• Trans fats incorporate into vascular endothelial membranes, producing severe endothelial dysfunction.
• Simultaneously elevate atherogenic LDL and lower protective HDL cholesterol, amplifying myocardial infarction and stroke risks.
• The WHO has called for global elimination of industrial trans fats.

Practical Intake Recommendations

• Total Fat Allowance: 20% to 35% of total daily caloric expenditure.
• Saturated Fats: Limit to under 10% of calories (under 5–6% for individuals with dyslipidemia).
• Core Strategy: Replace refined seed oils and animal lard with extra virgin olive oil, whole nuts, avocados, and cold-water marine fish (salmon, sardines, mackerel) 2–3 times weekly.